World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
70
Citations
21902
World Ranking
20066
National Ranking
689

Omgo E. Nieweg publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Omgo E. Nieweg sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 252 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Omgo E. Nieweg D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Omgo E. Nieweg sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 70 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Omgo E. Nieweg is affiliated with the Royal Prince Alfred Hospital in Australia and has contributed extensively to the field of medicine, with a strong focus on oncology. Their research intersects several subfields including molecular biology, epidemiology, artificial intelligence, and immunology.

The scientist's work spans multiple key topics related to melanoma and cancer research:

  • Cutaneous Melanoma Detection and Management
  • Melanoma and MAPK Pathways
  • Nonmelanoma Skin Cancer Studies
  • Cancer Immunotherapy and Biomarkers
  • AI in cancer detection
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research

Omgo E. Nieweg has published in several notable venues in the cancer research community, with frequent contributions to:

  • Annals of Surgical Oncology (12 publications)
  • Journal of Surgical Oncology (4 publications)
  • European Journal of Cancer (3 publications)
  • Journal of Clinical Oncology (2 publications)
  • British journal of surgery (2 publications)

Frequent collaborators include Andrew J. Spillane, John F. Thompson, Robyn P.M. Saw, Kerwin F. Shannon, and Serigne Lo, each with more than 25 joint works, indicating strong collaborative ties within surgical oncology and melanoma research teams.

Some recent significant papers authored or co-authored by Omgo E. Nieweg include:

  • Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma, 2021, Nature Medicine
  • Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes, 2022, Cancer Discovery
  • Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma, 2021, Annals of Oncology
  • Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma, 2022, JAMA Surgery
  • Histological regression in melanoma: impact on sentinel lymph node status and survival, 2021, Modern Pathology

Their research contributions emphasize the immunological and molecular underpinnings of melanoma treatment responses, neoadjuvant immunotherapy outcomes, and histopathological correlates of survival. The integration of artificial intelligence approaches is also evident in their work aimed at improving cancer detection methodologies.

Best Publications

  • Sentinel-node biopsy or nodal observation in melanoma

    Donald L. Morton;John F. Thompson;Alistair J. Cochran;Nicola Mozzillo

  • Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma

    D. L. Morton;J. F. Thompson;A. J. Cochran;N. Mozzillo

  • Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

    Mark B. Faries;John F. Thompson;Alistair J. Cochran;Robert H. Andtbacka

  • Validation of the Accuracy of Intraoperative Lymphatic Mapping and Sentinel Lymphadenectomy for Early-Stage Melanoma: A Multicenter Trial

    Donald L. Morton;John F. Thompson;Richard Essner;Robert Elashoff

  • Sentinel node biopsy for early-stage melanoma - Accuracy and morbidity in MSLT-I, an international multicenter trial

    Donald L. Morton;Alistair J. Cochran;John F. Thompson;Robert Elashoff

  • Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.

    Alexander A.M.M. Eggermont;Heimen Schraffordt Koops;Joseph J.M. Klausner;Bin B.B.R. Kroon

  • Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.

    Elisa A Rozeman;Alexander M Menzies;Alexander C J van Akkooi;Chandra Adhikari

  • PATIENTS WITH PENILE CARCINOMA BENEFIT FROM IMMEDIATE RESECTION OF CLINICALLY OCCULT LYMPH NODE METASTASES

    B.K. Kroon;S. Horenblas;A.P. Lont;P.J. Tanis

  • Lymphatic drainage patterns from the breast.

    Susanne H. Estourgie;Omgo E. Nieweg;Renato A. Valdés Olmos;Emiel J. Th. Rutgers

  • Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy.

    Pieter J Tanis;Omgo E Nieweg;Renato A Valdés Olmos;Bin B.R Kroon

  • Detection of unknown occult primary tumors using positron emission tomography

    Annemieke C. Kole;Omgo E. Nieweg M.D.;Omgo E. Nieweg M.D.;Jan Pruim M.D.;Harald J. Hoekstra M.D.

  • Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma.

    Joost A.P. Leijte;Bin K. Kroon;Renato A. Valdés Olmos;Omgo E. Nieweg

  • Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer.

    Omgo E. Nieweg M.D.;E. Edmund Kim;Wai-Hoi Wong;F B S William Broussard

  • The definition of a sentinel node.

    Omgo E. Nieweg;Pieter J. Tanis;Bin. B. R. Kroon

  • Comparing the Hybrid Fluorescent–Radioactive Tracer Indocyanine Green–99mTc-Nanocolloid with 99mTc-Nanocolloid for Sentinel Node Identification: A Validation Study Using Lymphoscintigraphy and SPECT/CT

    Oscar R. Brouwer;Tessa Buckle;Lenka Vermeeren;W. Martin C. Klop

  • DETECTION OF OCCULT METASTASIS IN SQUAMOUS CELL CARCINOMA OF THE PENIS USING A DYNAMIC SENTINEL NODE PROCEDURE

    Simon Horenblas;Liesbeth Jansen;Willem Meinhardt;Cornelis A. Hoefnagel

  • Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature.

    I.M.C. van der Ploeg;O.E. Nieweg;M.C. van Rijk;R.A. Valdés Olmos

  • Positron emission tomography for staging of oesophageal and gastroesophageal malignancy

    AC Kole;JT Plukker;OE Nieweg;W Vaalburg

  • Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

    E. A. Rozeman;E. P. Hoefsmit;I. L. M. Reijers;R. P. M. Saw;R. P. M. Saw;R. P. M. Saw

  • Ultrasonography and Fine-Needle Aspiration Cytology Can Spare Breast Cancer Patients Unnecessary Sentinel Lymph Node Biopsy

    Maartje C. van Rijk;Eline E. Deurloo;Omgo E. Nieweg;Kenneth G. A. Gilhuijs

Frequent Co-Authors

Pieter J. Tanis
Pieter J. Tanis University of Amsterdam
Emiel J. Th. Rutgers
Emiel J. Th. Rutgers Antoni van Leeuwenhoek Hospital
Simon Horenblas
Simon Horenblas Antoni van Leeuwenhoek Hospital
Johannes L. Peterse
Johannes L. Peterse Antoni van Leeuwenhoek Hospital
Alexander M.M. Eggermont
Alexander M.M. Eggermont Institut Gustave Roussy
John F. Thompson
John F. Thompson University of Sydney
Harald J. Hoekstra
Harald J. Hoekstra University Medical Center Groningen
Alistair J. Cochran
Alistair J. Cochran University of California, Los Angeles
Donald L. Morton
Donald L. Morton Saint John's Health Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternatives to studying Medicine in the USA? There are many online degree paths and healthcare careers available, providing flexibility and great job prospects.

Many non-nursing graduates consider direct entry msn online programs, which let you fast-track into advanced nursing roles without a prior nursing degree. These programs combine professional healthcare training with flexible scheduling, making them ideal for career changers.

If you’re looking for a less intensive entry to healthcare, online bsn programs for non nurses offer a pathway into nursing, with some schools featuring less competitive admissions. Entry requirements vary, but there are programs designed specifically for those new to the field.

Other high-demand options include medical billing and coding. Many schools offer financial aid for medical billing and coding programs, making this career pathway accessible even to those with limited resources.

Prospective LPN students often ask: do you have to take a teas test for lpn? Some nursing programs now waive standardized entry exams, simplifying the application process.

Best Scientists Citing Omgo E. Nieweg

Trending Scientists

Recently Published Articles